757 related articles for article (PubMed ID: 29220347)
1. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the impact of biannual school-based and community-wide treatment on urogenital schistosomiasis in Niger.
Phillips AE; Tohon Z; Dhanani NA; Sofo B; Gnandou I; Sidikou B; Noma AG; Madougou B; Alto O; Sebangou H; Halilou KM; Andia R; Garba A; Fenwick A; Hamidou AA
Parasit Vectors; 2020 Nov; 13(1):557. PubMed ID: 33203477
[TBL] [Abstract][Full Text] [Related]
3. Urogenital schistosomiasis in Cabo Delgado, northern Mozambique: baseline findings from the SCORE study.
Phillips AE; Gazzinelli-Guimarães PH; Aurelio HO; Dhanani N; Ferro J; Nala R; Deol A; Fenwick A
Parasit Vectors; 2018 Jan; 11(1):30. PubMed ID: 29316983
[TBL] [Abstract][Full Text] [Related]
4. Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey.
Knopp S; Person B; Ame SM; Ali SM; Muhsin J; Juma S; Khamis IS; Rabone M; Blair L; Fenwick A; Mohammed KA; Rollinson D
Parasit Vectors; 2016 Jan; 9():5. PubMed ID: 26727915
[TBL] [Abstract][Full Text] [Related]
5. Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d'Ivoire: a SCORE study protocol.
Tian-Bi YT; Ouattara M; Knopp S; Coulibaly JT; Hürlimann E; Webster B; Allan F; Rollinson D; Meïté A; Diakité NR; Konan CK; N'Goran EK; Utzinger J
BMC Public Health; 2018 Jan; 18(1):186. PubMed ID: 29378542
[TBL] [Abstract][Full Text] [Related]
6. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of integrated interventions layered on mass drug administration for urogenital schistosomiasis elimination: a cluster-randomised trial.
Knopp S; Person B; Ame SM; Ali SM; Hattendorf J; Juma S; Muhsin J; Khamis IS; Mohammed KA; Utzinger J; Hollenberg E; Kabole F; Rollinson D
Lancet Glob Health; 2019 Aug; 7(8):e1118-e1129. PubMed ID: 31255591
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period.
Senghor B; Diaw OT; Doucoure S; Sylla SN; Seye M; Talla I; Bâ CT; Diallo A; Sokhna C
Parasit Vectors; 2015 Jul; 8():362. PubMed ID: 26156522
[TBL] [Abstract][Full Text] [Related]
10. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso.
Touré S; Zhang Y; Bosqué-Oliva E; Ky C; Ouedraogo A; Koukounari A; Gabrielli AF; Bertrand S; Webster JP; Fenwick A
Bull World Health Organ; 2008 Oct; 86(10):780-7, A. PubMed ID: 18949215
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
12. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
[TBL] [Abstract][Full Text] [Related]
13. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
[TBL] [Abstract][Full Text] [Related]
14. Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy.
Ouedraogo H; Drabo F; Zongo D; Bagayan M; Bamba I; Pima T; Yago-Wienne F; Toubali E; Zhang Y
Bull World Health Organ; 2016 Jan; 94(1):37-45. PubMed ID: 26769995
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d'Ivoire.
Assaré RK; N'Tamon RN; Bellai LG; Koffi JA; Mathieu TI; Ouattara M; Hürlimann E; Coulibaly JT; Diabaté S; N'Goran EK; Utzinger J
Parasit Vectors; 2020 Jul; 13(1):337. PubMed ID: 32616074
[TBL] [Abstract][Full Text] [Related]
16. Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment.
Landouré A; Dembélé R; Goita S; Kané M; Tuinsma M; Sacko M; Toubali E; French MD; Keita AD; Fenwick A; Traoré MS; Zhang Y
PLoS Negl Trop Dis; 2012; 6(7):e1774. PubMed ID: 22860153
[TBL] [Abstract][Full Text] [Related]
17. A 5-Year intervention study on elimination of urogenital schistosomiasis in Zanzibar: Parasitological results of annual cross-sectional surveys.
Knopp S; Ame SM; Person B; Hattendorf J; Rabone M; Juma S; Muhsin J; Khamis IS; Hollenberg E; Mohammed KA; Kabole F; Ali SM; Rollinson D
PLoS Negl Trop Dis; 2019 May; 13(5):e0007268. PubMed ID: 31059495
[TBL] [Abstract][Full Text] [Related]
18. Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal.
Senghor B; Diaw OT; Doucoure S; Seye M; Diallo A; Talla I; Bâ CT; Sokhna C
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004557. PubMed ID: 27015646
[TBL] [Abstract][Full Text] [Related]
19. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
[TBL] [Abstract][Full Text] [Related]
20. Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial
Secor WE; Wiegand RE; Montgomery SP; Karanja DMS; Odiere MR
Am J Trop Med Hyg; 2020 Feb; 102(2):318-327. PubMed ID: 31802733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
